CLL: Treatment and Management Strategies for Best Outcomes - Episode 8
Focusing on acalabrutinib-based treatment, Yuliya Linhares, MD, discusses results from the ELEVATE TN clinical trial.
Related Content:
Myelofibrosis Survivor Reflects on the Impact of Her Physician
Advice for Patients Newly Diagnosed With Multiple Myeloma
A Five-Time Cancer Survivor’s Advice for Patients
Orserdu Combo Shows Potential for ER+/HER2– Breast Cancer